Drug Channels

JUNE 21, 2022

National Association of Specialty Pharmacy (NASP) 2022 Annual Meeting & Expo. September 19-22, 2022 | Gaylord Palms Resort & Convention Center | Orlando, FL. The National Association of Specialty Pharmacy (NASP) will host the NASP 2022 Annual Meeting & Expo September 19-22.

Specialty Pharmacies 83

Specialty Pharmacies Pharmacy Nurses Hospitals 83

Drug Channels

MAY 23, 2023

In 2022, the PBM market remained highly consolidated—although there were some intriguing share shifts among the largest players. Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription claims. to 1:30 p.m.

Pharmacy 93

Pharmacy Marketing Drugs 93

Drug Channels

MAY 17, 2022

Two weeks ago, Paula and I had the pleasure of attending Asembia’s 2022 Specialty Pharmacy Summit at the wonderful Wynn Las Vegas. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Below, I violate Vegas code and tell you what happened there. You’ll also find a link to my general session slides and some fun photos.

Specialty Pharmacies 85

Specialty Pharmacies Pharmacy Drugs Hospitals 85

Drug Channels

JULY 27, 2022

Click here to see the original post from May 2022. In Drug Channels Institute’s list of the top 15 pharmacies of 2021 , we show that central-fill, mail pharmacies operated by large PBMs and health insurers have displaced retail chains as the largest prescription drug dispensers by revenues. d/b/a Drug Channels Institute.

Specialty Pharmacies 79

Specialty Pharmacies Pharmacy Drugs 79

Drug Channels

OCTOBER 13, 2022

The other is my mapping of the insurer/PBM/specialty pharmacy/provider organizations that now dominate U.S. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. One is my chart showing the key channel flows within the entire U.S. pharmaceutical distribution, payment, and reimbursement system. drug channels.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 97

Drug Channels

NOVEMBER 13, 2024

What’s more, the share of plans with a preferred cost sharing pharmacy network will fall to its lowest rate in more than 10 years. The destruction of the Part D market marks yet another unintended consequence of the Inflation Reduction Act of 2022 (IRA).

Pharmacy 86

Pharmacy Marketing Drugs 86

Drug Channels

MARCH 1, 2022

The Centers for Medicare & Medicaid Services (CMS) has recently released its 2022 data on enrollment in Medicare Part D prescription drug plans (PDPs). Our exclusive analysis of these numbers finds that for 2022, an astounding 99% of seniors are enrolled in the wonderland of PDPs with preferred pharmacy networks.

Pharmacy 96

Pharmacy Marketing Drugs 96

Drug Channels

MAY 3, 2022

In Drug Channels Institute’s list of the top 15 pharmacies of 2021 , we show that central-fill, mail pharmacies operated by large PBMs and health insurers have displaced retail chains as the largest prescription drug dispensers by revenues. But as I explain below, 2022 will be a year of transition. d/b/a Drug Channels Institute.

Specialty Pharmacies 76

Specialty Pharmacies Pharmacy Drugs 76

Drug Channels

OCTOBER 22, 2024

billion (+23.4%) higher than its 2022 counterpart. Lobbyists claim that manufacturers’ 340B contract pharmacy changes are “stripping billions of dollars from the healthcare safety net.” Reality has again failed to support the spin surrounding the 340B Drug Pricing Program. billion—an astounding $12.6 billion (+$5.5 Only in the U.S.

Pharmacy 80

Pharmacy Hospitals Drugs 80

Drug Channels

FEBRUARY 21, 2023

Pharmacies and Pharmacy Benefit Managers. Pharmacies and Pharmacy Benefit Managers is a definitive, nonpartisan resource that includes the most current information about pharmacy dispensing channels, third-party payers, pharmacy benefit managers (PBMs), patients’ financial contributions, government regulations, and much more.

Pharmacy 75

Pharmacy Specialty Pharmacies Licensing Licensing 75

Drug Channels

MARCH 14, 2022

Asembia’s Specialty Pharmacy Summit 2022. May 2 – 5, 2022 | Las Vegas www.asembiasummit.com. Asembia's Specialty Pharmacy Summit 2022 is back! This is a must-attend event for anyone connected to specialty pharmacy. Read on for more details about this great specialty pharmacy event and register now.

Specialty Pharmacies 54

Specialty Pharmacies Pharmacy FDA Science 54

Drug Channels

NOVEMBER 2, 2021

Open enrollment is under way for the 2022 Medicare Part D plans. Our exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that preferred cost sharing pharmacy networks will maintain their dominance as an established component of Part D benefit design.

Pharmacy 91

Pharmacy Independent Pharmacies Drugs 91

Drug Channels

JULY 20, 2022

In this issue: CVS disassociates itself from its chain pharmacy association Payers are paying attention to ICER Benefits of the biosimilar boom A fantastic takedown of health insurance deductibles Plus, I join the Advisory Board of Alto Pharmacy. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. to 1:30 p.m.

Biosimilars 80

Biosimilars Pharmacy Drugs Marketing 80

Drug Channels

DECEMBER 7, 2022

In yesterday’s post , I highlighted the largest pharmacy chains that will participate in the 2023 Medicare Part D prescription drug plans (PDP). What's more, plans from Aetna, Humana, WellCare, and UnitedHealthcare will not have any independent pharmacies participating via PSAOs as preferred pharmacies. to 1:30 p.m.

Pharmacy 94

Pharmacy Independent Pharmacies Drugs 94

Drug Channels

APRIL 26, 2022

Next week, I'll be live and in-person at Asembia's Specialty Pharmacy Summit. During Tuesday's general session, I'll be joining Dr. Scott Gottlieb for a fireside chat at 8:00 AM and will then present my "State of Specialty Pharmacy 2022" at 9:30 AM. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Pharmacy 81

Pharmacy Specialty Pharmacies Doctors Drugs 81

Drug Channels

AUGUST 6, 2024

In the video excerpt below, I walk through a brief history of 340B contract pharmacies. I conclude with a “follow the dollar” example of 340B prescription economics with contract pharmacies. If this clip whets your appetite for more, register to watch a replay of the full 90-minute video webinar from June. All rights reserved.

Pharmacy 52

Pharmacy Hospitals Marketing Drugs 52

Drug Channels

JANUARY 23, 2024

In a previous article , I highlighted the largest pharmacy chains that will participate in the 2024 Medicare Part D prescription drug plans (PDP). Plans from Aetna, Humana, WellCare, and UnitedHealthcare will not have any independent pharmacies participating via PSAOs as preferred pharmacies. Look out below!

Pharmacy 62

Pharmacy Independent Pharmacies Marketing Drugs 62

Drug Channels

DECEMBER 20, 2022

Drug Channels also had a big 2022. Wishing you and your family health and happiness, Adam Ring in 2023 with our final news roundup of the year: A vertical integration update Walgreens backs away from prescriptions Meet a cash-pay pharmacy that’s not owned by a billionaire Time to cure or kill 340B? d/b/a Drug Channels Institute.

Pharmacy 73

Pharmacy Drugs 73

Drug Channels

MARCH 14, 2023

Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Pharmacies and Pharmacy Benefit Managers , our 14th edition, provides a comprehensive, fact-based, and non-partisan tool for understanding the entire U.S. I am pleased to announce our new 2023 Economic Report on U.S.

Pharmacy 86

Pharmacy Drugs Marketing Biosimilars 86

Drug Channels

SEPTEMBER 21, 2022

In 2022, specialty pharmacies—via white, brown, and clear bagging—now constitute a meaningful share of the distribution channels for provider-administered oncology drugs. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. The battle for control of the specialty patient continues. d/b/a Drug Channels Institute.

Specialty Pharmacies 73

Specialty Pharmacies Hospitals Pharmacy Pharmaceuticals 73

Drug Channels

JANUARY 24, 2023

Below I examine the latest data on pharmacy benefits: cost sharing tier structures, copayment vs. coinsurance, and out-of-pocket obligations. As you will see, pharmacy benefit designs again increased the use of coinsurance for specialty and fourth-tier drugs. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Pharmacy 52

Pharmacy Drugs 52

Drug Channels

JUNE 6, 2022

The retail pharmacy shakeout affected 2021 pharmacist employment. We found that retail pharmacies and drugstores employed fewer pharmacists, while hospitals and outpatient centers continued to add positions. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Expect further declines as the shakeout continues.

Pharmacy 96

Pharmacy Hospitals Marketing Drugs 96

Drug Channels

OCTOBER 2, 2024

The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

DECEMBER 12, 2022

Click here to see the original post and comments from September 2022. By now, you have already read innumerable articles explaining what’s in the new Inflation Reduction Act of 2022 (IRA; P.L. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Biosimilars 97

Biosimilars Pharmacy Hospitals Marketing 97

Drug Channels

JUNE 23, 2023

Below I examine the latest data on pharmacy benefits: cost sharing tier structures, copayment vs. coinsurance, and out-of-pocket obligations. As you will see, pharmacy benefit designs again increased the use of coinsurance for specialty and fourth-tier drugs.

Pharmacy 76

Pharmacy Drugs 76

Drug Channels

DECEMBER 15, 2023

For 2022, discounted purchases under the 340B program reached a record $53.7 Hospitals accounted for 87% of 340B purchases for 2022. Another surprise: HRSA estimated that manufacturers' contract pharmacy restrictions reduced 340B purchases by only $470 million—or less than 1% of 2022's total purchases.

Pharmacy 80

Pharmacy Hospitals Drugs 80

Drug Channels

MARCH 8, 2022

Next week, Drug Channels Institute will release our 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. The total share of the largest 15 companies decreased slightly compared with their 2020 share, due primarily to below-market growth rates at retail and long-term care pharmacies.

Pharmacy 84

Pharmacy Marketing Drugs 84

Drug Channels

FEBRUARY 15, 2022

Time to update Drug Channels' exclusive look at independent pharmacy owners’ business economics. Our analysis again reveals that despite what you may have heard, many independent pharmacies continue to hang on in a highly challenging retail environment. retail pharmacy industry faces many powerful headwinds.

Independent Pharmacies 83

Independent Pharmacies Pharmacy Vaccine Drugs 83

Drug Channels

NOVEMBER 15, 2022

The rise of discount card pricing within pharmacy benefit plans is a positive development. However, I suspect few people understand that placing discount cards within the pharmacy benefit enables a PBM to monetize a new fee stream from the card vendor. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Links below.

Pharmacy 87

Pharmacy Drugs Marketing 87

Drug Channels

SEPTEMBER 24, 2023

For 2022, discounted purchases under the 340B program reached a record $53.7 Hospitals accounted for 87% of 340B purchases for 2022. Another surprise: HRSA estimated that manufacturers' contract pharmacy restrictions reduced 340B purchases by only $470 million—or less than 1% of 2022's total purchases.

Pharmacy 69

Pharmacy Hospitals Drugs 69

Drug Channels

MARCH 27, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. Click here to see the original post and comments from November 2022. Click here to see the original post and comments from November 2022.

Pharmacy 77

Pharmacy Drugs Marketing 77

Drug Channels

NOVEMBER 16, 2021

In Consolidation and Preferred Pharmacy Networks in 2022’s Medicare Part D Plans , I highlighted how those networks have hijacked the world of stand-alone Medicare Part D prescription drug plans (PDP) and become a major presence in Medicare Advantage prescription drug (MA-PD) plans. to 1:30 p.m. Click here to learn more and sign up.

Pharmacy 83

Pharmacy Drugs Marketing 83

Drug Channels

NOVEMBER 1, 2022

Our exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that preferred cost sharing pharmacy networks will maintain their dominance as an established component of Part D benefit design. The largest companies made only minor changes to their 2023 stand-alone plans, after streamlining their 2022 plans.

Pharmacy 85

Pharmacy Independent Pharmacies Drugs 85

Drug Channels

MAY 24, 2022

As the market for patient-paid prescriptions has expanded, disputes about the appropriate split of these spreads will pressure pharmacy-PBM relationships and drive change in the discount card business model. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Read on and see what you think. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JULY 11, 2022

Informa Connect's Hub and Specialty Pharmacy Models West. September 14-15, 2022 Sheraton San Diego Hotel & Marina | San Diego, CA www.informaconnect.com/hub-specialty-pharmacy-west. Copyright © 2006-2022 Pembroke Consulting, Inc. Delivered as a Hybrid Event. Attorney’s Office District of NJ Gustav W.

Specialty Pharmacies 82

Specialty Pharmacies Pharmacy Biosimilars Compliance 82

Drug Channels

JANUARY 19, 2022

For 2022, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)— increased the number of drugs they excluded from their standard formularies. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Each exclusion list contains 400 to 500 products.

Biosimilars 94

Biosimilars Pharmacy Drugs Production 94

FDA Law Blog: Biosimilars

MARCH 24, 2024

By Faraz Siddiqui — As drug manufacturers battle the Health Resources and Services Administration (“HRSA”) in federal courts over the role of 340B contract pharmacies, an Eighth Circuit decision to uphold a 2021 Arkansas law may render those cases inconsequential in that state. Code Ann. § 23-92-604(c)(1), (2) (Act 1103). Decision at 8-9.

Pharmacy 57

Pharmacy Regulations Compliance Drugs 57